RCMI Coordinating Center (RCMI CC) Header Logo

Gehan Devendra

Concepts (67)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Monocytes
1
2023
257
0.760
 Why?
Shock, Septic
1
2019
20
0.700
 Why?
Cardiotonic Agents
1
2019
37
0.690
 Why?
Leukocytes, Mononuclear
2
2024
234
0.250
 Why?
Pulmonary Fibrosis
1
2024
31
0.230
 Why?
Pulmonary Surfactant-Associated Proteins
1
2002
2
0.210
 Why?
Pulmonary Surfactants
1
2002
26
0.200
 Why?
Lung Diseases
1
2002
61
0.190
 Why?
Milrinone
1
2019
4
0.180
 Why?
Dobutamine
1
2019
7
0.180
 Why?
Epinephrine
1
2019
36
0.180
 Why?
Pseudolymphoma
1
2019
5
0.170
 Why?
Shock, Cardiogenic
1
2019
10
0.170
 Why?
Myocarditis
1
2019
20
0.170
 Why?
Cytokines
1
2023
602
0.170
 Why?
Hospital Mortality
1
2019
187
0.160
 Why?
Cross-Sectional Studies
1
2023
2721
0.130
 Why?
Humans
8
2024
37093
0.120
 Why?
Retrospective Studies
1
2019
2026
0.120
 Why?
Pulmonary Embolism
2
2011
32
0.110
 Why?
Endarterectomy
1
2011
1
0.100
 Why?
Methylprednisolone
1
2011
14
0.100
 Why?
Preoperative Care
1
2011
26
0.100
 Why?
Lung Injury
1
2011
15
0.100
 Why?
Thrombectomy
1
2011
13
0.100
 Why?
Heparin, Low-Molecular-Weight
1
2007
8
0.080
 Why?
Heparin
1
2007
35
0.080
 Why?
Thrombocytopenia
1
2007
21
0.080
 Why?
Anticoagulants
1
2007
102
0.070
 Why?
Myeloid Cells
1
2024
29
0.060
 Why?
Sequence Analysis, RNA
1
2024
106
0.060
 Why?
Vascular Endothelial Growth Factor A
1
2024
161
0.050
 Why?
Granulocytes
1
2022
29
0.050
 Why?
Disease Progression
1
2024
601
0.050
 Why?
Phenotype
1
2022
689
0.040
 Why?
Ampicillin
1
2019
6
0.040
 Why?
Dyspnea
1
2019
18
0.040
 Why?
Lung
1
2002
446
0.040
 Why?
Immunosuppressive Agents
1
2019
76
0.040
 Why?
Cohort Studies
1
2022
1492
0.040
 Why?
Electrocardiography
1
2019
156
0.040
 Why?
Antiviral Agents
1
2019
157
0.040
 Why?
Case-Control Studies
1
2019
1130
0.030
 Why?
Hawaii
1
2019
1929
0.030
 Why?
Injections, Intravenous
1
2011
62
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2011
56
0.020
 Why?
Interleukin-8
1
2011
60
0.020
 Why?
Interleukin-10
1
2011
75
0.020
 Why?
Glucocorticoids
1
2011
86
0.020
 Why?
Double-Blind Method
1
2011
286
0.020
 Why?
Interleukin-6
1
2011
153
0.020
 Why?
Follow-Up Studies
1
2011
974
0.020
 Why?
Dose-Response Relationship, Drug
1
2011
1039
0.020
 Why?
Venous Thrombosis
1
2007
28
0.020
 Why?
Aged
1
2019
6741
0.020
 Why?
Confidence Intervals
1
2007
149
0.020
 Why?
Treatment Outcome
1
2011
1369
0.020
 Why?
Prospective Studies
1
2011
1378
0.020
 Why?
Female
2
2019
20969
0.020
 Why?
Randomized Controlled Trials as Topic
1
2007
268
0.020
 Why?
Odds Ratio
1
2007
534
0.020
 Why?
Animals
1
2002
15081
0.020
 Why?
Incidence
1
2007
922
0.020
 Why?
Risk Assessment
1
2007
753
0.020
 Why?
Adult
1
2019
11712
0.010
 Why?
Middle Aged
1
2011
10129
0.010
 Why?
Male
1
2011
20025
0.010
 Why?
Devendra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (67)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support